Biolinq Inc announced that it will receive $109,511,762 in a round of funding on September 2, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12,290 KRW | +29.92% | +86.78% | +194.37% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
290 CAD | 0.00% | 0.00% | 526M | ||
110 USD | -1.96% | +3.67% | 5.93B | ||
1st Jan change | Capi. | |
---|---|---|
+194.37% | 276M | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- A294090 Stock
- News EOFLOW Co.,Ltd.
- Biolinq Inc announced that it expects to receive funding